跳至主要内容
临床试验/ITMCTR2200005956
ITMCTR2200005956尚未招募4 期

A multicenter, randomized, double-blind study on the efficacy and safety of Gongxuening capsules in reducing postoperative bleeding after induced abortion

Peking Union Medical College Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
20 至 40(—)
性别
Female

入选标准

  • 1. 20 years old = age = 40 years old;
  • 2. Women with intrauterine pregnancy = 10 weeks and requiring termination of pregnancy without contraindications;
  • 3. Regular menstrual cycle in the past half a year, no recent (half a year) history of induced abortion;
  • 4. The subjects voluntarily signed the informed consent form.

排除标准

  • 1. Those who are allergic to the experimental drugs;
  • 2. Subjects with contraindications to induced abortion;
  • 3. Those with uterine malformation and large uterine fibroids;
  • 4. Those with abnormal coagulation function who are using anticoagulant or hemostatic drugs;
  • 5. Other circumstances judged by the investigator to be inappropriate for inclusion.

研究者

相似试验

进行中(未招募)
3 期
In this study the effectiveness and safety of topical Forskolin (0.15%) will be compared with standard drug-topical Timolol (0.5%) in patients with ocular hypertension or open angle glaucoma.
CTRI/2020/01/022887SamiSabinsa Group Limited
进行中(未招募)
不适用
A multicenter, randomized, double-blind study with 2 groups as prove of concept for the treatment of ACE induced angioedema with subcutaneous Icatibant - AMACEThe study objective is to assess the efficacy and safety of the Bradykinin-2 (BK-2) receptor antagonist Icatibant compared to a historic group of 47 patients with ACE inhibitor induced angioedema which we have been previously treated in our centers with current standard” therapy (250 mg methylprednisolon and 2 mg clemastine).
EUCTR2009-015410-22-DEMedizinische Fakultaet der Technischen Universitaet Muenchen30
进行中(未招募)
不适用
A study of RoActemra/Actemra (tocilizumab) in combination with methotrexate in patients with rheumatoid arthritis with inadequate response to prior treatment with methotrexate and low disease activity with the combination de RoActemra/Actemra y methotrexate.MedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid arthritis
EUCTR2011-001626-15-ESRoche Farma, S.A.
进行中(未招募)
不适用
A double-blind, randomized, multi-center study with 500 mg QD of TRO19622 versus placebo in patients with painful peripheral diabetic neuropathy
EUCTR2006-004545-42-LVTROPHOS180
进行中(未招募)
不适用
A double-blind, randomized, multi-center study with 500 mg QD of TRO19622 versus placebo in patients with painful peripheral diabetic neuropathy
EUCTR2006-004545-42-DETROPHOS180